DK0538193T3 - Kondenserede cycloaliphatiske amidinohydrazon-salte som inhibitorer af S-adenosylmethionindecarboxylase - Google Patents

Kondenserede cycloaliphatiske amidinohydrazon-salte som inhibitorer af S-adenosylmethionindecarboxylase

Info

Publication number
DK0538193T3
DK0538193T3 DK92810767.1T DK92810767T DK0538193T3 DK 0538193 T3 DK0538193 T3 DK 0538193T3 DK 92810767 T DK92810767 T DK 92810767T DK 0538193 T3 DK0538193 T3 DK 0538193T3
Authority
DK
Denmark
Prior art keywords
acids
acid
unsubstituted
substituted
apart
Prior art date
Application number
DK92810767.1T
Other languages
English (en)
Inventor
Joerg Dr Frei
Jaroslav Dr Stanek
Giorgio Dr Caravatti
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of DK0538193T3 publication Critical patent/DK0538193T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
DK92810767.1T 1991-10-16 1992-10-08 Kondenserede cycloaliphatiske amidinohydrazon-salte som inhibitorer af S-adenosylmethionindecarboxylase DK0538193T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16

Publications (1)

Publication Number Publication Date
DK0538193T3 true DK0538193T3 (da) 1996-12-23

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92810767.1T DK0538193T3 (da) 1991-10-16 1992-10-08 Kondenserede cycloaliphatiske amidinohydrazon-salte som inhibitorer af S-adenosylmethionindecarboxylase

Country Status (24)

Country Link
EP (1) EP0538193B1 (da)
JP (1) JP2788579B2 (da)
KR (1) KR100265307B1 (da)
AT (1) ATE145896T1 (da)
AU (1) AU658931B2 (da)
CA (1) CA2080545C (da)
CY (1) CY2127B1 (da)
CZ (1) CZ279601B6 (da)
DE (1) DE59207617D1 (da)
DK (1) DK0538193T3 (da)
ES (1) ES2095444T3 (da)
FI (1) FI112212B (da)
GR (1) GR3021903T3 (da)
HK (1) HK1005023A1 (da)
HU (1) HU226954B1 (da)
IL (1) IL103448A (da)
MX (1) MX9205934A (da)
NO (1) NO178108C (da)
NZ (1) NZ244725A (da)
RU (1) RU2081108C1 (da)
SA (1) SA93130417B1 (da)
SG (1) SG43185A1 (da)
SK (1) SK279938B6 (da)
ZA (1) ZA927957B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
CA2210533C (en) * 1995-01-26 2007-12-04 Novartis Ag Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
AU2003221482A1 (en) * 2002-03-04 2003-09-16 Boehringer Ingelheim Pharma Gmbh And Co. Kg Novel cinnamate salts, method for production and use thereof as medicaments
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
FI924650A0 (fi) 1992-10-14
IL103448A (en) 1998-01-04
EP0538193A2 (de) 1993-04-21
IL103448A0 (en) 1993-03-15
RU2081108C1 (ru) 1997-06-10
HUT63149A (en) 1993-07-28
EP0538193B1 (de) 1996-12-04
NO178108C (no) 1996-01-24
CA2080545A1 (en) 1993-04-17
NO924001D0 (no) 1992-10-15
KR930007896A (ko) 1993-05-20
MX9205934A (es) 1993-04-01
ES2095444T3 (es) 1997-02-16
NO924001L (no) 1993-04-19
ZA927957B (en) 1993-04-26
ATE145896T1 (de) 1996-12-15
SK315292A3 (en) 1995-04-12
HU226954B1 (en) 2010-03-29
GR3021903T3 (en) 1997-03-31
DE59207617D1 (de) 1997-01-16
SA93130417B1 (ar) 2005-11-12
NO178108B (no) 1995-10-16
HU9203234D0 (en) 1992-12-28
AU658931B2 (en) 1995-05-04
NZ244725A (en) 1995-05-26
CA2080545C (en) 2005-11-29
FI924650A (fi) 1993-04-17
AU2704092A (en) 1993-04-22
SK279938B6 (sk) 1999-06-11
KR100265307B1 (ko) 2000-09-15
CY2127B1 (en) 2002-06-21
SG43185A1 (en) 1997-10-17
EP0538193A3 (en) 1993-06-16
CZ279601B6 (cs) 1995-05-17
HK1005023A1 (en) 1998-12-18
FI112212B (fi) 2003-11-14
JPH05239011A (ja) 1993-09-17
JP2788579B2 (ja) 1998-08-20
CZ315292A3 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
FI863013A (fi) Bakterisida framstaellningar foer anvaendning inom veterinaermedicinen.
ES8600243A1 (es) Procedimiento para la obtencion de compuestos de 2-hidroximetil-3-carbamoil-1,4-dihidropiridina
HUT46658A (en) Process for producing pharmaceutical compositions with lincotriene antagonist effect, comprising aromatic thioether derivatives as active ingredient
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ATE43344T1 (de) Neue 1-hydroxy-1,1-diphosphonsaeureverbindungen, verf. zu ihrer herstellung u. pharmakologische zubereitungen, insb. zur behandlung von knochentumoren.
KR900009645A (ko) 축합된 퀴놀린계 화합물 및 그의 제조방법
DK0538193T3 (da) Kondenserede cycloaliphatiske amidinohydrazon-salte som inhibitorer af S-adenosylmethionindecarboxylase
MX9206245A (es) Nuevas ftalazinas, que en la posicion 1 contienen una agrupacion eter o tioeter y el procedimiento para su elaboracion.
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
BR0206036A (pt) Derivados de ácido benzóico substituìdos tendo ação de inibição de nf-kb
ES539160A0 (es) Un procedimiento para preparar derivados de penem
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
SE8802814D0 (sv) Beredningar for lokal anvendning
EP0663384A3 (de) Salze der Pyromellitsäure, ein Verfahren zu ihrer Herstellung sowie deren Verwendung.
NO900646D0 (no) Fremgangsmaate for fremstilling av calsiumantagonister.
SE8400629L (sv) Basiska oximetrar
ATE212982T1 (de) Verfahren zur herstellung von fluoro-chinolin-3- carbonsäurederivate
TH19223A (th) การผลิตและวิธีใช้อนุพันธ์ของแลคทอล
NO950061L (no) 4-oksa-1-azabisyklo [3,2,0Å heptan-7-on-derivater som antitumormidler